Investment Summary

EQT Life Sciences Invests In binx health

On July 21, 2021, growth capital firm EQT Life Sciences invested in healthcare services company binx health

Investment Highlights
  • This is EQT Life Sciences’ 1st transaction in the Healthcare Services sector.
  • This is EQT Life Sciences’ 8th transaction in the United States.
  • This is EQT Life Sciences’ 2nd transaction in Massachusetts.

Investment Summary

Date 2021-07-21
Target binx health
Sector Healthcare Services
Investor(s) EQT Life Sciences
Deal Type Venture

Target

binx health

Cambridge, Massachusetts, United States
binx health is a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study and shop. binx health was founded in 2005 and is based in Cambridge, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 38 of 47
Sector: Healthcare Services M&A 1 of 1
Type: Venture M&A Deals 32 of 39
State: Massachusetts M&A 2 of 3
Country: United States M&A 8 of 11
Year: 2021 M&A 6 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-09 Muna Therapeutics

Copenhagen , Denmark

Muna Therapeutics is a neurology focused biotech company working on developing novel therapeutics for neurodegenerative diseases. Muna Therapeutics was founded in 2020 and is based in Copenhagen, Denmark.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-10 Visus Therapeutics

Seattle, Washington, United States

Visus Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, Visus Therapeutics was founded in 2019 and is based in Seattle, Washington.

Buy -